Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Ver Heyen, M; Heymans, S; Antoons, G; Reed, T; Periasamy, M; Awede, B; Lebacq, J; Vangheluwe, P; Dewerchin, M; Collen, D; Sipido, K; Carmeliet, P; Wuytack, F.
Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.
Circ Res. 2001; 89(9):838-846 Doi: 10.1161/hh2101.098466 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Antoons Gudrun
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The cardiac sarco(endo)plasmic reticulum Ca(2+)-ATPase gene (ATP2A2) encodes the following two different protein isoforms: SERCA2a (muscle-specific) and SERCA2b (ubiquitous). We have investigated whether this isoform specificity is required for normal cardiac function. Gene targeting in mice successfully disrupted the splicing mechanism responsible for generating the SERCA2a isoform. Homozygous SERCA2a(-/-) mice displayed a complete loss of SERCA2a mRNA and protein resulting in a switch to the SERCA2b isoform. The expression of SERCA2b mRNA and protein in hearts of SERCA2a(-/-) mice corresponded to only 50% of wild-type SERCA2 levels. Cardiac phospholamban mRNA levels were unaltered in SERCA2a(-/-) mice, but total phospholamban protein levels increased 2-fold. The transgenic phenotype was characterized by a approximately 20% increase in embryonic and neonatal mortality (early phenotype), with histopathologic evidence of major cardiac malformations. Adult SERCA2a(-/-) animals (adult phenotype) showed a reduced spontaneous nocturnal activity and developed a mild compensatory concentric cardiac hypertrophy with impaired cardiac contractility and relaxation, but preserved beta-adrenergic response. Ca(2+) uptake levels in SERCA2a(-/-) cardiac homogenates were reduced by approximately 50%. In isolated cells, relaxation and Ca(2+) removal by the SR were significantly reduced. Comparison of our data with those obtained in mice expressing similar cardiac levels of SERCA2a instead of SERCA2b indicate the importance of the muscle-specific SERCA2a isoform for normal cardiac development and for the cardiac contraction-relaxation cycle.
Find related publications in this database (using NLM MeSH Indexing)
Alternative Splicing -
Animals -
Calcium - metabolism Calcium - pharmacokinetics
Calcium-Binding Proteins - genetics Calcium-Binding Proteins - metabolism
Calcium-Transporting ATPases - deficiency Calcium-Transporting ATPases - genetics Calcium-Transporting ATPases - metabolism
Cardiomegaly - etiology Cardiomegaly - pathology Cardiomegaly - physiopathology
Cardiotonic Agents - pharmacology
Dobutamine - pharmacology
Gene Targeting -
Heart - drug effects Heart - physiopathology
Heart Defects, Congenital - pathology Heart Defects, Congenital - physiopathology
Isoenzymes - deficiency Isoenzymes - genetics Isoenzymes - metabolism
Isoproterenol - pharmacology
Mice -
Mice, Mutant Strains -
Myocardial Contraction - drug effects Myocardial Contraction - genetics
Myocardium - metabolism Myocardium - pathology
Patch-Clamp Techniques -
Phenotype -
RNA, Messenger - metabolism
Sarcoplasmic Reticulum - metabolism
Sarcoplasmic Reticulum Calcium-Transporting ATPases -
Survival Rate -

Find related publications in this database (Keywords)
Ca(2+)-transporting ATPase
alternative splicing
gene targeting
cardiovascular abnormalities
cardiomegaly
© Med Uni GrazImprint